AAGP eNews
Nov. 18, 2014

Survey invitation from the University of Rhode Island
AAGP
AAGP members and affiliates are invited to participate in a survey on strategies and policies for management of behavioral disturbances in dementia, focused on the acute care setting. The researchers are reaching out to different types of healthcare providers to gather information on best practices and policies surrounding psychotropic medication use in older adults. The survey takes approximately 10 minutes to complete, and can be found here. More

Anxiety speeds cognitive impairment, Alzheimer's disease
Healthline
A new study shows that people with mild cognitive impairment and high levels of stress have a greater risk of developing Alzheimer's disease than their peers who aren't stressed out. According to an article in the American Journal of Geriatric Psychiatry, MCI patients who experience anxiety symptoms tend to undergo a speedier decline in cognitive function, whether or not they have depression, which is also a risk factor for Alzheimer's.More

Researchers identify new neurological disorder linked to Alzheimer's
Medical News Today
The research team — co-led by Dr. Peter T. Nelson of the Sanders-Brown Center on Aging at the University of Kentucky and Dr. John F. Crary of Mount Sinai Hospital in New York, NY — call the disease primary age-related tauopathy (PART). Patients with Alzheimer's disease have tangles in their brain made up of a protein called tau, as well as plaques caused by build-up of a protein called beta-amyloid. But the team says that patients with PART only have tangles, not plaques.More

Researchers: Alzheimer's cases expected to double by 2050
HealthDay via U.S. News & World Report
The number of people with Alzheimer's disease in the United States will more than double by 2050 — a trend driven by the aging baby boomer population, a new study predicts. The cost of caring for these Alzheimer's patients will climb from $307 billion to $1.5 trillion a year by 2050, the researchers estimated. They believe that, 35 years from now, the average annual per-patient cost of the disease will be double that of the $71,000-a-year cost in 2010.More

How does Alzheimer's disease kill?
LiveScience via Fox News
Alzheimer's is perhaps best known for its effects on memory, but the condition is a progressive brain disease in which abnormal protein deposits build up in the brain, which causes brain cells to die. But Alzheimer's disease is not usually a direct cause of brain death — that is, it does not suddenly cause the entire brain to cease functioning, said Dr. Marc L. Gordon, chief of neurology at Zucker Hillside Hospital in Queens, New York.More

Caring for dementia patients takes a toll on baby boomers
Reuters Health via Philly.com
Baby boomers caring for people with dementia face special difficulties and significantly more strain and depression than other caregivers, according to a recent study. "(Caregivers) of people with dementia are experiencing more caregiving strains, interrupted sleep, and depressed feeling than boomer (caregivers) of people without dementia," the study's lead author Heehyul Moon said in an email. More

Injections to prevent Alzheimer's may be possible after researchers discover how to deliver antibodies to brain tissue
National Post
A weekly injection that could prevent Alzheimer's disease may be possible after scientists discovered how to introduce drugs into the brain. Treating neurological disorders such as dementia has always proved difficult because the brain has a network of blood vessels — known as the blood-brain barrier — that stops all but vital nutrients getting inside.More

Nobel Prize winners map path forward for Alzheimer's research
By Denise A. Valenti
The Nobel Peace Prize in Physiology or Medicine for 2014 was awarded to John O'Keefe, May-Britt Moser and Edvard Moser. The award calls attention to their study of the brain cells that are damaged in Alzheimer's disease, and it recognizes the discovery of brain cells that form a positioning mechanism in our brain. These cells are located in the hippocampus and entorhinal cortex, the same regions devastated early in the course of Alzheimer's disease. More

The Dutch village where everyone has dementia
The Atlantic
Today, the isolated village of Hogewey lies on the outskirts of Amsterdam in the small town of Wheesp. Dubbed "Dementia Village" by CNN, Hogewey is a cutting-edge elderly-care facility — roughly the size of 10 football fields — where residents are given the chance to live seemingly normal lives. With only 152 inhabitants, it's run like a more benevolent version of The Truman Show, if The Truman Show were about dementia and Alzheimer's patients. Like most small villages, it has its own town square, theater, garden and post office. More